X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (42) 42
female (32) 32
index medicus (27) 27
oncology (23) 23
cancer (22) 22
breast cancer (20) 20
middle aged (20) 20
chemotherapy (18) 18
breast neoplasms - drug therapy (17) 17
trastuzumab (13) 13
adult (12) 12
care and treatment (12) 12
chemotherapy, adjuvant (11) 11
disease-free survival (11) 11
aged (10) 10
research (10) 10
antineoplastic combined chemotherapy protocols - adverse effects (9) 9
antineoplastic combined chemotherapy protocols - therapeutic use (9) 9
breast neoplasms - mortality (9) 9
breast neoplasms - pathology (8) 8
therapy (8) 8
adjuvant chemotherapy (7) 7
breast neoplasms - surgery (7) 7
cyclophosphamide - administration & dosage (7) 7
doxorubicin - administration & dosage (7) 7
drug therapy (7) 7
medicine & public health (7) 7
metastasis (7) 7
neoplasm staging (7) 7
treatment outcome (7) 7
adolescent (6) 6
animals (6) 6
breast neoplasms - metabolism (6) 6
follow-up studies (6) 6
health aspects (6) 6
male (6) 6
recurrence (6) 6
survival analysis (6) 6
tamoxifen (6) 6
antineoplastic agents - therapeutic use (5) 5
clinical trials (5) 5
heart failure (5) 5
prognosis (5) 5
proportional hazards models (5) 5
receptor, erbb-2 - metabolism (5) 5
trial (5) 5
tumors (5) 5
adjuvant treatment (4) 4
aged, 80 and over (4) 4
analysis (4) 4
antibodies, monoclonal - therapeutic use (4) 4
antibodies, monoclonal, humanized (4) 4
antineoplastic combined chemotherapy protocols - administration & dosage (4) 4
article (4) 4
cancer therapies (4) 4
cardiotoxicity (4) 4
cardiovascular (4) 4
expression (4) 4
fluorouracil (4) 4
gene expression (4) 4
heart failure - chemically induced (4) 4
her2 (4) 4
internal medicine (4) 4
methods (4) 4
neoplasms - drug therapy (4) 4
original reports (4) 4
paclitaxel - administration & dosage (4) 4
receptors, estrogen - metabolism (4) 4
risk factors (4) 4
survival rate (4) 4
time factors (4) 4
women (4) 4
anthracyclines (3) 3
antibodies, monoclonal - adverse effects (3) 3
antibodies, monoclonal, humanized - administration & dosage (3) 3
antibodies, monoclonal, humanized - adverse effects (3) 3
antineoplastic agents (3) 3
antineoplastic agents - adverse effects (3) 3
biology (3) 3
biopsy (3) 3
bone marrow transplantation (3) 3
breast neoplasms - diagnosis (3) 3
breast neoplasms - genetics (3) 3
cancer patients (3) 3
carcinoma (3) 3
cells (3) 3
combined modality therapy (3) 3
comparative analysis (3) 3
complications and side effects (3) 3
diagnosis (3) 3
double-blind (3) 3
doxorubicin (3) 3
drug administration schedule (3) 3
estrogen (3) 3
follow-up (3) 3
genetic aspects (3) 3
hematology (3) 3
kaplan-meier estimate (3) 3
leukemia (3) 3
life sciences (3) 3
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (4) 4
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Gerstein Science - Circulation Desk (1) 1
Online Resources - Online (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UofT at Mississauga - On order (1) 1
UofT at Mississauga - Reference (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 09/2011, Volume 29, Issue 25, pp. 3366 - 3373
Journal Article
JAMA, ISSN 0098-7484, 03/2016, Volume 315, Issue 12, pp. 1280 - 1281
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2012, Volume 30, Issue 31, pp. 3792 - 3799
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2005, Volume 353, Issue 16, pp. 1673 - 1684
Journal Article
JAMA, The Journal of the American Medical Association, ISSN 0098-7484, 03/2016, Volume 315, Issue 12, p. 1280
The article presents diagnostic test interpretation of ERBB2 (HER2) testing in 35-year old women with breast cancer. It also provides alternative diagnostic... 
Immunohistochemistry | Care and treatment | Usage | Analysis | Breast cancer | Mammography | Diagnosis
Journal Article
JAMA: Journal of the American Medical Association, ISSN 0098-7484, 03/2016, Volume 315, Issue 12, pp. 1280 - 1280
ERBB2 (HER2) (the second human epidermal growth factor receptor discovered) is one of the most important tumor parameters to be evaluated for any patient... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. e12044 - e12044
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 01/2016, Volume 108, Issue 1, p. 1
  The benefits of breast cancer adjuvant systemic treatments are generally assumed to be proportional (or constant) over time, but limited data suggest that... 
Chemotherapy | Clinical trials | Systematic review | Time | Breast cancer | Effects
Journal Article
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 12/2013, Volume 105, Issue 23, p. 1782
  National Surgical Adjuvant Breast and Bowel Project (NSABP) trial B-31 suggested the efficacy of adjuvant trastuzumab, even in HER2-negative breast cancer.... 
Monoclonal antibodies | Medical tests | Breast cancer | Gene expression | Clinical outcomes
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 12/2013, Volume 105, Issue 23, pp. 1782 - 1788
Journal Article
Journal Article